Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jelle R Miedema

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Pulmonary Medicine|July 14, 2020
Looking into the future of sarcoidosis: what is next for treatment?Jelle R Miedema, Francesco Bonella, Johan Grunewald, et al.
Journal of Autoimmunity|January 10, 2018
Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?Jelle R Miedema, Ylva Kaiser, Caroline E Broos, et al.
Access Microbiology|October 16, 2020
The tough process of unmasking the slow-growing mycobacterium: case report of <i>Mycobacterium microti</i> infectionCornelia A M van de Weg, Jurriaan E M de Steenwinkel, Jelle R Miedema, et al.
ERJ Open Research|December 24, 2025
The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort studyIllaa Smesseim, Anne E Wind, Jelle R Miedema, et al.
The European Respiratory Journal|November 13, 2025
Sarcoidosis: A State-Of-The-Art ReviewJelle R Miedema, Francesco Bonella, Katharina Buschulte, et al.
Respiration; International Review of Thoracic Diseases|May 27, 2021
The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort StudyCatharina C Moor, Nelleke C Tak van Jaarsveld, Catherine Owusuaa, et al.
Respiratory Research|June 1, 2022
Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter studyJelle R Miedema, Catharina C Moor, Marcel Veltkamp, et al.
Journal of Hematopathology|October 28, 2020
Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumoniaJan H von der Thüsen, Jasper van Bommel, Johan M Kros, et al.
Respiratory Research|May 7, 2024
Increased proportions of circulating PD-1<sup>+</sup> CD4<sup>+</sup> memory T cells and PD-1<sup>+</sup> regulatory T cells associate with good response to prednisone in pulmonary sarcoidosisJelle R Miedema, Lieke J de Jong, Vivienne Kahlmann, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 9, 2025
Screening for cardiac sarcoidosis: diagnostic approach and long-term follow-up in a tertiary centreNikki van der Velde, Anne Poleij, Mattie J Lenzen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Pulmonary Medicine|July 14, 2020
Looking into the future of sarcoidosis: what is next for treatment?Jelle R Miedema, Francesco Bonella, Johan Grunewald, et al.
Journal of Autoimmunity|January 10, 2018
Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?Jelle R Miedema, Ylva Kaiser, Caroline E Broos, et al.
Access Microbiology|October 16, 2020
The tough process of unmasking the slow-growing mycobacterium: case report of <i>Mycobacterium microti</i> infectionCornelia A M van de Weg, Jurriaan E M de Steenwinkel, Jelle R Miedema, et al.
ERJ Open Research|December 24, 2025
The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort studyIllaa Smesseim, Anne E Wind, Jelle R Miedema, et al.
The European Respiratory Journal|November 13, 2025
Sarcoidosis: A State-Of-The-Art ReviewJelle R Miedema, Francesco Bonella, Katharina Buschulte, et al.
Respiration; International Review of Thoracic Diseases|May 27, 2021
The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort StudyCatharina C Moor, Nelleke C Tak van Jaarsveld, Catherine Owusuaa, et al.
Respiratory Research|June 1, 2022
Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter studyJelle R Miedema, Catharina C Moor, Marcel Veltkamp, et al.
Journal of Hematopathology|October 28, 2020
Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumoniaJan H von der Thüsen, Jasper van Bommel, Johan M Kros, et al.
Respiratory Research|May 7, 2024
Increased proportions of circulating PD-1<sup>+</sup> CD4<sup>+</sup> memory T cells and PD-1<sup>+</sup> regulatory T cells associate with good response to prednisone in pulmonary sarcoidosisJelle R Miedema, Lieke J de Jong, Vivienne Kahlmann, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 9, 2025
Screening for cardiac sarcoidosis: diagnostic approach and long-term follow-up in a tertiary centreNikki van der Velde, Anne Poleij, Mattie J Lenzen, et al.
Pageof 2